Oncotarget Leads the Way on the Journey towards Life without Disease
Oncotarget is a medical journal that focuses on oncology. The journal publishes peer-reviewed research every week. The research papers are published online and hosted by Impact Journal Publishing. The journal was launched in 2010. It is indexed by various online medical search engines such as PubMed, Scopus and Biosis Previews.The journal is edited by Mikhail Blagosklonny, a renowned scientific researcher associated with Roswell Park Cancer Institute. Andrei Gudkov of the same institute serves as the co-editor-in-chief. In like manner, the list of the members of the editorial board is like a who’s who in oncology. The journal publishes the highest number of research papers on oncology. The journal membership includes numerous award-winning scientists.
The multidisciplinary journal goes beyond oncology. Research paper of Oncotarget in various disciplines such as neuroscience, pathology, microbiology, endocrinology, and cardiology among numerous others. The research papers are open access. Anyone can view them from the portal. It provides effective collaboration between the different disciplines of biomedical science. Oncotarget focuses on maximizing the impact of cancer research. Papers are widely and quickly distributed. Groundbreaking discoveries are shared quickly through the platform. This is achieved by employing an innovative peer-review model. You can submit your research paper quickly and easily through the portal. The review process is quick and efficient. Additionally, it is transparent, credible
The submission guidelines are posted on the portal. This includes tips for authors and reviewers as well as citation formatting instructions. The review process is simple. The author submits the paper and designates any preferred reviewers. The editors assign additional reviewers and allow them to work. After getting the reviewers feedback, the editor communicates the decision to the author. This expedites the review process. Authors normally get feedback within a month.The journal is a trendsetter in the industry. It has been at the forefront of publishing groundbreaking discoveries by renowned scientists. This includes advances in cancer therapy and the aging process, artificial intelligence, and conditions such as leukemia. It was the first to publish studies demonstrating the direct relationship between gum tissue damage and e-cigarettes. This disproves the notion that e-cigarettes are a healthier alternative.